Clinical Trials Sponsored by TranS1, Inc

Total 35419 results

Pfizer
Trans Tech Pharmaceuticals

Completed

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Alzheimer Disease

United States
Trans Tasman Radiation Oncology Group

Unknown

Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC) (CHISEL)

Non Small Cell Lung Cancer

Australia, New Zealand
Trans Tasman Radiation Oncology Group

Completed

Chemoradiation Treatment for Head and Neck Cancer

Head and Neck Cancer

Australia
Trans Tasman Radiation Oncology Group

Completed

Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer (BOLART)

Bladder Cancer

Australia, New Zealand
Trans Tasman Radiation Oncology Group

Completed

A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer (Local HER-O)

Breast Neoplasms

Australia
Trans Tasman Radiation Oncology Group

Active, not recruiting

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPVOropharynx)

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Australia, New Zealand
Trans Tasman Radiation Oncology Group

Completed

Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer (PROArCT)

Rectal Cancer

Australia
Trans Tasman Radiation Oncology Group

Recruiting

A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (OUTRUN)

Metastatic Non Small Cell Lung Cancer

Australia, Singapore
Trans Tasman Radiation Oncology Group

Active, not recruiting

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) (STARS)

Breast Cancer

Australia, New Zealand
Trans Tasman Radiation Oncology Group

Completed

Merkel Positron Emission Tomography (PET) Protocol (MP3)

Merkel Cell Carcinoma

Australia
Trans Tasman Radiation Oncology Group

Active, not recruiting

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney (FASTRACK II)

Renal Cell Carcinoma

Australia
Trans Tasman Radiation Oncology Group

Completed

Assessment of New Radiation Oncology Technologies and Treatments (ANROTAT)

Nasopharyngeal Cancer | Anal Cancer | Intermediate Risk Prostate Cancer | Prostate Cancer (Post Prostatectomy)

Australia
TRC GEN+ managed by Trans Russian co Cy
KGK Science Inc.

Completed

An Study Investigating Nic's Keto Diet on Cardiovascular Health in Healthy Adults With Mildly Elevated LDL Levels

Healthy | Ketogenic Dieting

Canada
Trans Tasman Radiation Oncology Group
3M

Completed

Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream

Breast Cancer

Australia
Trans Tasman Radiation Oncology Group
AstraZeneca

Recruiting

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy (CHEST RT)

Extensive-Stage Small-Cell Lung Cancer

Australia
University of Sydney
Trans Tasman Radiation Oncology Group

Unknown

Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (SPARK)

Prostate Cancer

Australia
UNC Lineberger Comprehensive Cancer Center
UNC Translational and Clinical Sciences (Tracs)

Completed

Retinal Oxygen Function After Radiation Therapy

A History of Radiation Therapy for a Tumor in the Vicinity of the Retina(s)

United States
Canadian Cancer Trials Group
Trans Tasman Radiation Oncology Group

Completed

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Spinal Metastases

Canada, Australia
Trans Tasman Radiation Oncology Group
Australasian Leukaemia and Lymphoma Group

Completed

Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma

Follicular Lymphoma

Australia, New Zealand, Canada
Trans Tasman Radiation Oncology Group
Australasian Lung Cancer Trials Group

Completed

A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II) (SAFRON II)

Cancer | Metastases to the Lung

Australia
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia

Completed

Accelerated Partial Breast Irradiation for Early Breast Cancer

Breast Cancer

Australia, New Zealand
Trans Tasman Radiation Oncology Group
Cancer Council New South Wales

Completed

SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).

Spinal Cord Compression From Neoplasm Metastasis

Australia
Douglas Trask

Terminated

Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

Gastro-esophageal Reflux

United States
Peter MacCallum Cancer Centre, Australia
Trans Tasman Radiation Oncology Group

Completed

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer (AZTEC)

Breast Cancer

Australia
Trans Tasman Radiation Oncology Group
Australasian Leukaemia and Lymphoma Group

Completed

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Primary Central Nervous System Lymphoma

Australia, New Zealand
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia

Completed

Lung Tumour Volume Database

Non-Small Cell Lung Cancer

Singapore, Australia, New Zealand
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia

Completed

Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer

Cancer of the Uterine Cervix

United States, Singapore, Australia, New Zealand, India
Elizabeth Krans, MD

Completed

Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection

Hepatitis C, Chronic | Opioid-use Disorder

United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Melanoma and Skin Cancer Trials Limited
Trans Tasman Radiation Oncology Group

Active, not recruiting

Neurotropic Melanoma of the Head and Neck (RTN2)

Melanoma

United States, Australia, United Kingdom
Trans Tasman Radiation Oncology Group
Bayer; Peter MacCallum Cancer Centre, Australia

Recruiting

Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA (DECREASE)

Advanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSA

Australia, Singapore
Institute of Cancer Research, United Kingdom
Trans Tasman Radiation Oncology Group

Active, not recruiting

Study of Tumour Focused Radiotherapy for Bladder Cancer (RAIDER)

Bladder Cancer

United Kingdom, New Zealand, Australia
Trans Tasman Radiation Oncology Group
Cancer Council Queensland; Victorian Cancer Council

Completed

Chemoradiotherapy in Patients With Localised Lung Cancer

Non Small Cell Lung Carcinoma

Australia
Diana Trang

Terminated

Frequency Specific Microcurrent for the Treatment of Diastasis Recti

Diastasis Recti

United States
Elizabeth Krans, MD
National Institute on Drug Abuse (NIDA); OpalGenix, Inc

Recruiting

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

Pregnancy Related | Opioid Use Disorder

United States
Trans Tasman Radiation Oncology Group
National Health and Medical Research Council, Australia

Completed

Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.

Transitional Cell Carcinoma of Urinary Bladder

Australia, New Zealand
Trans Tasman Radiation Oncology Group
Fisher and Paykel Healthcare; Auckland City Hospital

Completed

Radiotherapy With Humidification in Head And Neck Cancer (RadioHum)

Cancer of the Head and Neck

New Zealand
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); North Carolina TraCS Institute

Completed

Patient Preferences for Breast Reconstruction After Mastectomy

Breast Cancer

United States
Trans Tasman Radiation Oncology Group
The Royal Australian and New Zealand College of Radiologists

Completed

A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer

Gastric Cancer

Australia, New Zealand
Melanoma and Skin Cancer Trials Limited
University of Oxford; Trans Tasman Radiation Oncology Group

Active, not recruiting

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma (WBRTMel)

Metastatic Melanoma

Norway, Australia, United Kingdom
Instituto Aragones de Ciencias de la Salud
Refbio2: Trans-Pyrenean cooperation network for biomedical research

Completed

HMB for Denutrition in Patients With Cirrhosis (HEPATIC) (HEPATIC)

Malnutrition | Cirrhosis | Sarcopenia

Spain
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia; Australasian Leukaemia and Lymphoma...

Unknown

Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma

Non-gastric Marginal Zone Lymphoma

Australia
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Jaclyn Tran

Unknown

Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation

Constipation | Peritoneal Dialysis Complication

Canada
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
Ontario Clinical Oncology Group (OCOG)
Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...

Completed

PROFIT - Prostate Fractionated Irradiation Trial

Prostate Cancer

Canada, Australia, France
Trans Tasman Radiation Oncology Group
National Health and Medical Research Council, Australia; Canadian Cancer Trials...

Completed

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

Esophagus Cancer

Australia, Canada, New Zealand, United Kingdom

Clinical Trials Sponsored by TranS1, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations